The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study

The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation: a retrospective study

PurposeThis study investigated the effectiveness of an oral GnRH antagonist for retained products of conception (RPOC) carrying a risk of heavy bleeding.MethodsWith IRB approval and patient consent, this retrospective study included 97 RPOC cases after miscarriage. Clinical courses of the GnRH antag...

Full description

Saved in:
Bibliographic Details
Main Authors: Satoko Sasatsu, Yosuke Ono, Dai Miyashita, Tatsuya Yoshihara, Kota Tanaka, So Owada, Kana Makino, Akiko Nakagomi, Maki Ogi, Eriko Ogasawara, Hikaru Tagaya, Hiroko Fukasawa, Yasuhiko Okuda, Osamu Yoshino
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Medicine
Subjects:
GnRH antagonist
retained products of conception
surgical intervention
miscarriage
menstrual resumption
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1543272/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items